Rescue Stenting and Intravenous Thrombolysis in Patients with Large Vessel Ischemic Stroke
Launched by ASST SANTI PAOLO E CARLO · Dec 5, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment approach for patients who have had a large vessel ischemic stroke, which is a type of stroke caused by a blockage in the major blood vessels of the brain. The research focuses on using a procedure called rescue stenting, along with a medication called intravenous thrombolysis (IVT), to improve blood flow when the standard treatment, mechanical thrombectomy, doesn't work. By examining real-world strategies for preventing complications after stenting, the trial aims to find out how safe and effective these combined treatments are for patients.
To participate in this study, individuals must be at least 18 years old and have experienced a large vessel occlusion stroke that requires a thrombectomy and rescue stenting within 24 hours of the stroke starting. Participants will be monitored as the study looks at how well different medications work in managing their condition after the procedure. It's important to know that the trial is currently recruiting participants, and anyone interested will need to provide informed consent before joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with large vessel occlusion strokes undergoing thrombectomy and rescue stenting within 24 hours of stroke onset
- • Patients ≥ 18 years of age
- Exclusion Criteria:
- • Patients \< 18 years
- • Refusal to give informed consent
About Asst Santi Paolo E Carlo
ASST Santi Paolo e Carlo is a distinguished healthcare organization based in Italy, renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, it plays a pivotal role in facilitating innovative studies that contribute to the development of new therapies and treatment protocols. With a focus on collaboration and excellence, ASST Santi Paolo e Carlo leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct rigorous clinical trials across various therapeutic areas, ensuring adherence to the highest ethical and scientific standards. Through its research initiatives, the organization aims to enhance healthcare outcomes and foster the translation of scientific discoveries into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cesena, , Italy
Bergamo, , Italy
Milan, , Italy
Monza, Mb, Italy
Lecce, , Italy
Milan, , Italy
Pietra Ligure, , Italy
Patients applied
Trial Officials
Elena Ballabio, MD
Principal Investigator
ASST Santi Paolo e Carlo
Luca Valvassori, MD
Study Director
ASST Santi Paolo carlo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported